ArticleMolecular medicine (Cambridge, Mass.)2015

Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling.

Kerry-Ann Mcdonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.